Laparoscopic surgeons received their first glimpse of Cook Medical’s uterine manipulator/injectors (UMI) last week at the 38th Global Congress of Minimally Invasive Gynecology, sponsored by the American Association of Gynecologic Laparoscopists (AAGL).
Cook’s new UMI and UMI-Loc™ products, designed to improve laparoscopic procedures during the diagnosis and treatment of common gynecological problems such as infertility, pelvic organ prolapse, endometriosis, chronic pelvic pain, uterine fibroids, ovarian cysts and incontinence, debuted at AAGL accompanied by demonstrations of Cook’s Biodesign™ Advanced Tissue Repair line. Cook’s Biodesign product line is used in several gynecologic procedures including continence restoration, fistula repair, vaginal erosion repair and pelvic-floor reconstruction. Specifically, attendees at the show had the opportunity to learn more about how Cook’s UMI and UMI-Loc products work by helping physicians maneuver the uterus and gain access to the target tissue, thereby enhancing and facilitating treatment of incontinence.
More than two million women had surgery involving their pelvic anatomy in the United States in 2008, with a rising percentage undergoing laparoscopy: a minimally invasive technique in which a tiny camera and surgical tools are inserted through a small incision in the abdominal wall. Laparoscopic surgery often allows shorter recovery times and less discomfort than open surgery.